Clinical Trial Update: Specified Drug-Use Survey of Leuprorelin Acetate Injection Kit 11.25 mg "All-Case Investigation: Spinal and Bulbar Muscular Atrophy (SBMA)"

View source ↗

Summary

This update notes ongoing recruitment for an all-case investigation of leuprorelin acetate 11.25 mg injection kit for spinal and bulbar muscular atrophy (SBMA).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Spinal and Bulbar Muscular Atrophy

Drugs mentioned

• Leuprorelin Acetate Injection Kit 11.25 mg (leuprorelin acetate)

Snippet

Sponsor: Takeda | Conditions: Spinal and Bulbar Muscular Atrophy | Status: RECRUITING